Most MTC cases present point mutations of RET proto-oncogene that can occur sporadically or as hereditary germline events in the multiple endocrine neoplasia syndromes (MEN2A and MEN2B) or in familial medullary thyroid cancer (FMTC) (25). The gene discussed is RET; the disease is multiple endocrine neoplasia.